PALISADE BIO, INC. - Common Stock, par value $0.01 per share (PALI)

Historical Holders from Q2 2024 to Q2 2025

Symbol
PALI on Nasdaq
CUSIP
696389402
Type / Class
Equity / Common Stock, par value $0.01 per share
Shares outstanding
100M
All holders as of June 30, 2025
Q2 2025
Total 13F shares, excl. options
84.6K
Holdings value
$57.5K
% of all portfolios
0%
Grand Portfolio weight change
0%
Number of holders
11
Number of buys
5
Number of sells
-6
Average Value change %
0%
Average buys %
+0%
Average sells %
0%
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors

Significant Owners of PALISADE BIO, INC. - Common Stock, par value $0.01 per share (PALI)

Filer Ownership Change % Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
PERCEPTIVE ADVISORS LLC 9.99% $7.1M 12.2M Perceptive Advisors LLC Oct 2, 2025
Deep Track Capital, LP 9.99% $5.81M 10M Deep Track Capital, LP Oct 1, 2025
RA CAPITAL MANAGEMENT, L.P. 9.9% $5.76M 9.94M RA Capital Management, L.P. Oct 2, 2025
Commodore Capital LP 9.9% $5.62M 9.69M Commodore Capital LP Oct 1, 2025
Squadron Capital Management LLC 8.5% $4.79M 8.25M Squadron Capital Management LLC Oct 1, 2025
Point72 Asset Management, L.P. 6.2% $4.4M 7.59M Point72 Asset Management, L.P. Oct 6, 2025
ARMISTICE CAPITAL, LLC 9.99% 0% $340K $134K 472K +65.3% Armistice Capital, LLC Mar 31, 2025

Institutional Holders of PALISADE BIO, INC. - Common Stock, par value $0.01 per share (PALI)

Period Reported Shares, Excl. Options Value, Excl. Options Change Price Investors
2025 Q2 84.6K $57.5K -$119K $0.68 11
2025 Q1 261K $177K -$26.9K $0.68 11
2024 Q4 199K $329K +$211K $1.65 9
2024 Q3 62.1K $220K +$114K $3.55 8
2024 Q2 30.1K $135K +$135K $4.50 7